Indicator full name: Total pharmaceutical expenditure as % of total health expenditure
- Country/Area (COUNTRY/AREA)
- Supranational group of countries (COUNTRY_GRP)
- Sex (SEX)
- Year of measure (YEAR)
Years data is available: 1970—2019
Last updated: 22 November 2021
- WHO European Region
- Members of the European Union
- Members of the EU before May 2004 (EU15)
- Members of the EU after May 2004 (EU13)
- Commonwealth of Independent States
- Central Asian Republics Information Network members (CARINFONET)
- South-eastern Europe Health Network members (SEEHN)
- Nordic countries
- Small countries
The following abbreviations are used in the indicator titles:
Indicator code: E992708.T
The OECD definition is applied. It includes the consumption of pharmaceutical products supplied on prescriptions and obtained for self-medication (often referred to as over-the-counter products). Pharmaceuticals consumed in hospitals are excluded. The expenditure includes VAT and sales taxes, where applicable. The amount of consumption in hospitals is included under in-patient care.
The OECD Health Database is used as the primary data source for those countries that are OECD Member States._
Social Security since 2003. Pharmaceutical expenditure corresponds to the total of the provider
category Hc5 following the ?System of health accounts 2011? manual.
B&H, Health Insurance Fund of Federation of B&H; Health Insurance Fund of Republic of Srpska;
Department for Health of Brcko District
Corrections are in connection with the new definition, by which the pharmaceuticals consumed in
hospitals are excluded.
Estonia has provided total pharmaceutical expenditure as % of current health expenditure data for
Methodology. GDP estimates refer to ESA 2010 Methodology
Source: National Accounts, Central Bureau of Statistics.
Data for the period 1992-2012 have been estimated on the basis of the updated version of the
classification of economic activities (Ateco 2007, the national version of Nace Rev. 2) and of
products by activity (CPA 2008) and are consistent with the revised time series of national
2013: Since 2013, SHA 2011 methodology used. As per Eurostat request, data for years 2011 (26.4%)
and 2012 (25.8%) were recalculated using SHA 2011 methodology.
methodology. Since 2013 methodology of SHA2011 is used.
Deviation from the definition: Since 2013 current expenditure on health care is used instead of
total health expenditure.
in hospitals, mental hospitals, nursing homes etc. are not included in the pharmaceutical
pharmaceutical products supplied on prescriptions and obtained for self-medication (often referred
to as over-the-counter products). Pharmaceuticals consumed in hospitals are excluded.
health expenditure from state and local budgets.
Source: Ministry of Health, the Economy and Finance Department.
Deviation from the Definition: Data as at 31st December.